Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma

Tundra lists 1 OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT06134284

Clinical Study of OR for Second-line Treatment of Refractory MZL

The goal of this clinical trial is to test the overall response rate of Orelabrutinib combined with rituximab (OR regimen) for second-line treatment of relapsed/refractory marginal zone lymphoma.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2024-06-11

1 state

OR Regimen for Relapsed/Refractory Marginal Zone Lymphoma